REFERENCES
1. Middleton BF, Danchin M, Fathima P, Bines JE, Macartney K, Snelling TL. Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 - 2021. Vaccine.2023;41(3):636-648.
2. Collaborators GBDDD. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Infect Dis. 2018;18(11):1211-1228.
3. Lau YL, Fan Leung T, Sirvan Cetin B, et al. Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study. Vaccine. 2022;40(14):2184-2190.
4. Hartman RM, Cohen AL, Antoni S, et al. Risk Factors for Mortality Among Children Younger Than Age 5 Years With Severe Diarrhea in Low- and Middle-income Countries: Findings From the World Health Organization-coordinated Global Rotavirus and Pediatric Diarrhea Surveillance Networks. Clin Infect Dis. 2023;76(3):e1047-e1053.
5. Caddy S, Papa G, Borodavka A, Desselberger U. Rotavirus research: 2014-2020. Virus Res. 2021;304:198499.
6. Du Y, Chen C, Zhang X, et al. Global burden and trends of rotavirus infection-associated deaths from 1990 to 2019: an observational trend study. Virol J. 2022;19(1):166.
7. Bishop RF DG, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet. 1973;2(7841):1281-1283.
8. Mhango C, Mandolo JJ, Chinyama E, et al. Rotavirus Genotypes in Hospitalized Children With Acute Gastroenteritis Before and After Rotavirus Vaccine Introduction in Blantyre, Malawi, 1997-2019. J Infect Dis. 2022;225(12):2127-2136.
9. Matthijnssens J, Otto PH, Ciarlet M, Desselberger U, Van Ranst M, Johne R. VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol. 2012;157(6):1177-1182.
10. Mihalov-Kovacs E, Gellert A, Marton S, et al. Candidate new rotavirus species in sheltered dogs, Hungary. Emerg Infect Dis.2015;21(4):660-663.
11. Banyai K, Kemenesi G, Budinski I, et al. Candidate new rotavirus species in Schreiber’s bats, Serbia. Infect Genet Evol.2017;48:19-26.
12. Johne R, Tausch SH, Grutzke J, et al. Distantly Related Rotaviruses in Common Shrews, Germany, 2004-2014. Emerg Infect Dis.2019;25(12):2310-2314.
13. Luo S, Chen X, Yan G, et al. Emergence of human-porcine reassortment G9P[19] porcine rotavirus A strain in Guangdong Province, China.Front Vet Sci. 2022;9:1111919.
14. Hokororo A, Kidenya BR, Seni J, Mapaseka S, Mphahlele J, Mshana SE. Predominance of rotavirus G1[P8] genotype among under-five children with gastroenteritis in Mwanza, Tanzania. J Trop Pediatr.2014;60(5):393-396.
15. Lucien MAB, Esona MD, Pierre M, et al. Diversity of rotavirus strains circulating in Haiti before and after introduction of monovalent vaccine. IJID Reg. 2022;4:146-151.
16. Doro R, Laszlo B, Martella V, et al. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure? Infect Genet Evol. 2014;28:446-461.
17. Li J, Zhang Y, Yang Y, et al. Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age. Vaccine. 2019;37(27):3611-3616.
18. Chen S, Gao S, Li J, Li J, Duan ZJ. Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China. Vaccine. 2023;41(2):547-554.
19. Carvalho MF, Gill D. Rotavirus vaccine efficacy: current status and areas for improvement. Hum Vaccin Immunother.2019;15(6):1237-1250.
20. Cates JE, Tate JE, Parashar U. Rotavirus vaccines: progress and new developments. Expert Opin Biol Ther. 2022;22(3):423-432.
21. Wu Z, Li Q, Liu Y, et al. Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants. Virol Sin.2022;37(5):724-730.
22. Lu L, Zhong H, Jia R, et al. Prevalence and genotypes distribution of group A rotavirus among outpatient children under 5 years with acute diarrhea in Shanghai, China, 2012-2018. BMC Gastroenterol.2022;22(1):217.
23. Phan TG, Khamrin P, Quang TD, et al. Detection and genetic characterization of group A rotavirus strains circulating among children with acute gastroenteritis in Japan. J Virol.2007;81(9):4645-4653.
24. Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol.2004;31(4):259-265.
25. Gouvea V GR, Woods P, Taniguchi K, Clark HF, Forrester B, Fang ZY. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990;28(2):276-282.
26. Simmonds MK, Armah G, Asmah R, et al. New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J Clin Virol. 2008;42(4):368-373.
27. Wang JX, Zhou HL, Mo ZJ, et al. Burden of viral gastroenteritis in children living in rural China: Population-based surveillance. Int J Infect Dis. 2020;90:151-160.
28. Wang LP, Zhou SX, Wang X, et al. Etiological, epidemiological, and clinical features of acute diarrhea in China. Nat Commun.2021;12(1):2464.
29. Lu JG, B.C. Zhang, L.P. Mei, K.W. Lu, X.Y. Lu, Y.H. Rotavirus vaccine coverage in the 2013-2020 birth cohorts in Minhang district of Shanghai. Chinese Journal of Vaccines and Immunization2021;27(6):695-698.
30. Fu C, Wang M, Liang J, He T, Wang D, Xu J. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine.2007;25(52):8756-8761.
31. Fu C, He Q, Xu J, et al. Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children. Vaccine.2012;31(1):154-158.
32. Wu D, Yen C, Yin ZD, et al. The Public Health Burden of Rotavirus Disease in Children Younger Than Five Years and Considerations for Rotavirus Vaccine Introduction in China. Pediatr Infect Dis J.2016;35(12):e392-e398.
33. Yu J, Lai S, Geng Q, et al. Prevalence of rotavirus and rapid changes in circulating rotavirus strains among children with acute diarrhea in China, 2009-2015. J Infect. 2019;78(1):66-74.
34. do Nascimento LG, Fialho AM, de Andrade J, de Assis RMS, Fumian TM. Human enteric adenovirus F40/41 as a major cause of acute gastroenteritis in children in Brazil, 2018 to 2020. Sci Rep.2022;12(1):11220.
35. Maison N, Peck A, Illi S, et al. The rising of old foes: impact of lockdown periods on ”non-SARS-CoV-2” viral respiratory and gastrointestinal infections. Infection. 2022;50(2):519-524.
36. Grochowska M, Ambrozej D, Wachnik A, Demkow U, Podsiadly E, Feleszko W. The Impact of the COVID-19 Pandemic Lockdown on Pediatric Infections-A Single-Center Retrospective Study. Microorganisms.2022;10(1).
37. Hoque SA, Khandoker N, Thongprachum A, et al. Distribution of rotavirus genotypes in Japan from 2015 to 2018: Diversity in genotypes before and after introduction of rotavirus vaccines. Vaccine.2020;38(23):3980-3986.
38. Baoming Jiang JRG, Roger I Glass. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis. 2002;34(10):1351-1361.
39. Elias MM. Distribution and titres of rotavirus antibodies in different age groups. J Hyg (Lond). 1977;79(3):365-372.
40. Satayarak J, Strauss ST, Duangdee C, et al. Prevalence and diversity of human rotavirus among Thai adults. J Med Virol.2020;92(11):2582-2592.
41. Wang SJ, Chen LN, Wang SM, et al. Genetic characterization of two G8P[8] rotavirus strains isolated in Guangzhou, China, in 2020/21: evidence of genome reassortment. BMC Infect Dis. 2022;22(1):579.
42. Taniguchi K UT, Urasawa S. Independent segregation of the VP4 and the VP7 genes in bovine rotaviruses as confirmed by VP4 sequence analysis of G8 and G10 bovine rotavirus strains. J Gen Virol.1993;74(Pt 6):1215-1221.
43. Hasegawa A, Inouye S, Matsuno S, Yamaoka K, Eko R, Suharyono W. Isolation of human rotaviruses with a distinct RNA electrophoretic pattern from Indonesia. Microbiol Immunol. 1984;28(6):719-722.
44. Tapia MD, Armah G, Breiman RF, et al. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa. Vaccine. 2012;30 Suppl 1:A79-85.
45. Ma W, Wei Z, Guo J, et al. Effectiveness of Pentavalent Rotavirus Vaccine in Shanghai, China: A Test-Negative Design Study. J Pediatr. 2023;259:113461.
46. Mukhopadhya I, Murdoch H, Berry S, et al. Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland. Vaccine. 2017;35(1):156-163.
47. Sadiq A, Bostan N, Yinda KC, Naseem S, Sattar S. Rotavirus: Genetics, pathogenesis and vaccine advances. Rev Med Virol.2018;28(6):e2003.
48. Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact. Expert Rev Vaccines.2018;17(7):593-606.
49. Hoa-Tran TN, Nakagomi T, Vu HM, et al. Abrupt emergence and predominance in Vietnam of rotavirus A strains possessing a bovine-like G8 on a DS-1-like background. Arch Virol. 2016;161(2):479-482.